from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1717/-

LFCtreatmentdescriptionclass of inhibitor

0.061

Amikacinug/mL Amikacintranslation

-1.093

Cap5-10ug/mL Capreomycintranslation

0.550

Rox10-50 ug/mL Roxithromycintranslation

1.281

SM2-5 ug/mL Streptomycintranslation

1.420

Tet5-10 ug/mL Tetracyclinetranslation

0.738

Rif0.2-5ug/mL Rifampicintranscription

0.148

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.342

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.069

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.567

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.293

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.497

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.031

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.677

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.833

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.569

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.183

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.534

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.961

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.752

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.091

Nigericin50 uM Nigericinrespiration

0.485

TRC10-150 ug/mL Triclosanrespiration

-0.275

TRZ10-25 ug/mL Thioridazinerespiration

-0.283

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.474

menadione6-10 ug/mL Menadionerespiration

0.293

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.050

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.281

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.265

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.538

NRP_1Non-replicating persistence stage 1dosRassociated

-0.211

Amp0.2mg/mL AmpicillincellWall

0.678

Cephalexin20-100 ug/mL CephalexincellWall

1.052

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.311

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.025

EMB10-20 ug/mL EthambutolcellWall

0.932

Eta12-40 ug/mL EthionamidecellWall

0.266

INH0.2-0.4 ug/mL IsoniazidcellWall

0.404

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.235

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.138

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.552

BZA0.12 mg/mL BenzamidearomaticAmides

0.884

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.464

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.226

H2O24 mM hydrogen peroxideDNAdamaging

0.096

Levo10 ug/mL LevofloxacinDNAdamaging

0.183

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.719

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.928

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.223

UVUV-irradiationDNAdamaging

-1.175

ARP41-4 ug/mL Antitubercular compound ARP4?

0.197

Antimycin12.5-50 ug/mL Antimycin A?

0.107

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.017

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.289

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.022

PA8240.2-2 ug/mL PA-824?

0.167

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.032

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.073

Verapamil50 uM Verapamil?

-0.353

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.057

methoxatin10-20 ug/mL Methoxatin?